The report concludes that many researchers now believe that
producing a stem cell therapy for Parkinson’s disease is realistic and the article ends
with a quote from the ex-director of the National Institute of Health’s Center
for Regenerative Medicine who comments that “these are the first steps in what
could be a revolutionary treatment”.
We're happy to see that the scientific and medical communities are beginning to recognize that stem cell therapy is a viable option in the treatment of Parkinson's disease. We look
forward to reporting progress from our own Parkinson’s disease clinical trial
which we are expecting to begin as soon as we receive regulatory
approval (see the January 29, 2015 press release for more information).
You can read the full article (behind Scientific American's pay-wall) here.
|